Insider filing · CPRX

Molly Harper sold $622K of Catalyst Pharmaceuticals (CPRX)

Executed Dec 12 2025, disclosed Dec 16 2025, 4 days later.

Returns are measured on stock purchases only.

MH Molly Harper Director profile →

Molly Harper (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in CPRX. The largest single filing was $622K of CPRX (26,746 sh across 3 lots, as filed), executed Dec 12 2025.

CPRX CPRX CPRX · 20 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→